Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Shares Issued (2016 - 2026)

Integra Lifesciences Holdings' Shares Issued history spans 17 years, with the latest figure at $957000.0 for Q1 2025.

  • On a quarterly basis, Shares Issued fell 85.04% to $957000.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $957000.0, a 85.04% decrease, with the full-year FY2025 number at $957000.0, down 85.04% from a year prior.
  • Shares Issued hit $957000.0 in Q1 2025 for Integra Lifesciences Holdings, down from $6.4 million in the prior quarter.
  • Over the last five years, Shares Issued for IART hit a ceiling of $6.4 million in Q1 2024 and a floor of $225000.0 in Q4 2023.
  • Historically, Shares Issued has averaged $1.8 million across 5 years, with a median of $1.2 million in 2022.
  • Biggest five-year swings in Shares Issued: surged 1541.1% in 2022 and later tumbled 94.19% in 2023.
  • Tracing IART's Shares Issued over 5 years: stood at $236000.0 in 2021, then surged by 1541.1% to $3.9 million in 2022, then tumbled by 94.19% to $225000.0 in 2023, then soared by 2743.56% to $6.4 million in 2024, then plummeted by 85.04% to $957000.0 in 2025.
  • Business Quant data shows Shares Issued for IART at $957000.0 in Q1 2025, $6.4 million in Q1 2024, and $225000.0 in Q4 2023.